January 18, 2018 / 12:59 PM / in 5 months

U.S. Chamber backs GSK bid to reverse ruling allowing Louisiana lawsuit

The U.S. Chamber of Commerce is supporting GlaxoSmithKline’s bid to overturn a court decision allowing the state of Louisiana to bring antitrust claims against the drugmaker even though it did not opt out of a related, previous class action settlement.

The Chamber filed a brief on Tuesday asking the full 3rd U.S. Circuit Court of Appeals in Philadelphia to review a three-judge panel’s decision holding Louisiana’s sovereign immunity meant it was not bound by a deal resolving claims that GSK tried to delay generic versions of its allergy drug Flonase.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2mST6yO

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below